Kamada Ltd (KMDA) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Kamada Ltd   (NASDAQ: KMDA)


Kamada Ltd's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Kamada Ltd's ROI in the fourth quarter of 2025?
Kamada Ltd achieved a return on average invested assets (ROI) of 6.89 % in its fourth quarter of 2025, which is below Kamada Ltd's average return on investment, which stands at 7.16%.

Despite the deterioration in its net income, company has improved ROI compared to the third quarter of 2025.

Within the Healthcare sector 162 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 1378.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM -6.6 % -1.35 % 4.13 % 15.51 % 29.31 %
Y / Y Net Income Change TTM 39.66 % 7.95 % 26.11 % 50.82 % 74.58 %
Investment (TTM) in Millions 301 297 292 284 323
Return On Investment (TTM) 6.89 % 6.84 % 6.26 % 5.21 % 4.6 %
KMDA's Overall Ranking # 1378 # # # #
Seq. Investment Change TTM -1.84 % -1.66 % -1.49 % -1.77 % 3.67 %
Seq. Net Income Change TTM -1.2 % 7.54 % 18.37 % 11.06 % -23.64 %
Net Income (TTM) in Millions 20 20 19 16 14

KMDA Company Profile >> Back to KMDA Roi Comparisons >> See Annual KMDA Return On Investment



Return On Investment KMDA's Ranking
Within: No.
Industry # 61
Sector # 163
Overall # 1378

Return On Investment Statistics
High Average Low
19.46 %
7.16 %
-1.55 %
(Dec 31 2018)   (Dec 31 2022)







Financial Statements
Kamada Ltd's IV. Quarter Investments $ 301 Millions KMDA's Balance sheet
Kamada Ltd's IV. Quarter Income $ 4 Millions Quarterly KMDA's Income Statement
KMDA's Income by Division See KMDA's Income by Division


KMDA Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 301 323 278 196 241
Y / Y Investment Growth -6.82 % 15.97 % 41.96 % -18.52 % 29.61 %
Net Income in Millions 20 14 8 -2 -2
Y / Y Net Income Growth 39.66 % 74.58 % - - -
Annual Return On Investment 6.71 % 4.48 % 2.98 % -1.18 % -0.93 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 6.71 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
KMDA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for KMDA's Competitors
Subscribers only: Roi for Kamada Ltd's Suppliers
Subscribers only: Return On Investment for KMDA's Customers

Other Ratios
KMDA's Roa KMDA's Inventory Turnover Ratio KMDA's Growth Rates KMDA's Dividend Statistics
KMDA's Profitability Ratios KMDA's Asset Turnover Ratio KMDA's Dividend Growth
KMDA's Roe KMDA's Valuation Ratios KMDA's Financial Strength Ratios KMDA's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI
United Therapeutics Corporation  18.71 %
Krystal Biotech Inc   18.51 %
Agilent Technologies inc   18.50 %
Chemed Corporation  18.05 %
Hca Healthcare Inc   17.95 %
Sbc Medical Group Holdings Incorporated  17.85 %
Lifevantage Corp  17.77 %
Embecta Corp   17.69 %
Waters Corporation  17.39 %
Spero Therapeutics Inc   16.92 %
Johnson and Johnson  16.85 %
Halozyme Therapeutics Inc   16.47 %
Intuitive Surgical Inc   15.81 %
Black Diamond Therapeutics Inc   15.47 %
Strata Critical Medical Inc   15.07 %
Aveanna Healthcare Holdings Inc   14.96 %
Ironwood Pharmaceuticals inc   14.88 %
Argenx Se  14.81 %
Corcept Therapeutics Inc  14.64 %
Harmony Biosciences Holdings inc   14.44 %
Keros Therapeutics Inc   13.88 %
Sab Biotherapeutics Inc   13.87 %
West Pharmaceutical Services Inc   13.68 %
Inmode Ltd   13.49 %
Neurocrine Biosciences Inc   13.45 %
Alkermes Plc   12.98 %
Regeneron Pharmaceuticals Inc   12.63 %
Novartis Ag  12.62 %
Universal Health Services Inc   12.38 %
Lantheus Holdings Inc   12.33 %

Date modified: 2026-09-18T14:10:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.